Key result
Nanoformulated linseed oil reduces ex vivo monocyte inflammation in ~63% of CAD patients via FPR2.
Why the study?
Atherosclerosis in CAD is driven by pro-inflammatory macrophages, and while omega-3 fatty acids promote anti-inflammatory macrophage polarization, the impact of stabilized nanoformulated linseed oil on resolving pro-inflammatory macrophages in monocytes from healthy donors and CAD patients needed investigation.
Does ex vivo treatment with nanoformulated linseed oil reduce monocyte-driven inflammation and oxidative stress in patients with coronary artery disease?
Does ex vivo treatment with nanoformulated linseed oil reduce monocyte-driven inflammation and oxidative stress in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
Nanoformulated linseed oil exerts potent ex vivo anti-inflammatory and antioxidant effects in monocytes from a subset of coronary artery disease patients via an FPR2-dependent mechanism, highlighting inter-individual variability in responsiveness based on FPR2 expression.
Introduction Atherosclerosis underlying coronary artery disease (CAD) is driven by inflammatory cells such as pro-inflammatory macrophages. Omega-3 fatty acids mitigate inflammation by promoting macrophage polarization toward an anti-inflammatory phenotype. Aim To study the impact of stabilized nanoformulated (NF) linseed oil (25% w/w) containing 13.75% (w/w) alpha-linolenic acid (ALA), a vegetal source of omega-3 fatty acids, on resolution of pro-inflammatory macrophages using monocytes from healthy donors and CAD patients. Methods Monocytes isolated from blood samples of healthy donors (n = 14) or CAD patients (n = 30) were studied. Gene expression was measured by RT-qPCR, protein levels by Western blot, cytokine release by ELISA, and reactive oxygen species (ROS) by dihydroethidium (DHE) staining. Cellular glucose uptake and intracellular calcium levels were also assessed. Results TNF-α and IL-6 polarized healthy donor monocytes into pro-inflammatory macrophages, marked by increased CD86, iNOS, ROS, and pro-inflammatory cytokines. NF linseed oil—unlike NF corn oil—significantly reduced ROS in a concentration-dependent manner and decreased major inflammatory, adhesion, pro-coagulant, remodeling, and calcification markers. CAD monocytes displayed markedly elevated basal ROS levels (54.4 ± 4.2 A.U.) versus TNF-α and IL-6 activated healthy donor monocytes (40.8 ± 2.8 A.U.). In CAD patients with elevated circulating pro-inflammatory cytokines, NF linseed oil (0.003%, 24 h) reduced IL-6, TNF-α, CD86, tissue factor, p47phox, ACE1, and MMP-9 expression in monocytes from 19 “Responders,” while monocytes from 11 patients showed no response and were classified as “Non-responders”. NF linseed oil also decreased ROS generation and suppressed metabolic activity (glucose uptake) and Ca²⁺ signaling in TNF-α and IL-6-polarized healthy monocytes and responder CAD monocytes, these effects were absent in non-responder cells. In responder CAD monocytes, its inhibitory actions were blocked by the FPR2 antagonist WRW4, but not by the GPR18 antagonist O1918 or an FPR1 antagonist, demonstrating a selective FPR2-dependent mechanism. Furthermore, FPR2 gene expression was significantly downregulated in non-responder CAD monocytes, consistent with their lack of responsiveness to NF linseed oil. Conclusion NF linseed oil exerts potent anti-inflammatory, antioxidant, and anti-remodeling effects in polarized pro-inflammatory monocytes from healthy donors and in CAD responder monocytes. The identification of distinct responder and non-responder subgroups, evident across molecular, inflammatory, and functional assays, highlights substantial inter-individual variability in monocyte responsiveness. These findings suggest that NF linseed oil may serve as a promising immunomodulatory strategy for targeting monocyte-driven inflammation in cardiovascular disease, while underscoring the need to define the determinants of patient-specific responsiveness.
No takes yet. Share an insight, caveat, or question.
Hmadeh et al. (2026) studied Coronary artery disease (n=44). Stabilized nanoformulated linseed oil (25% w/w) containing 13.75% (w/w) alpha-linolenic acid vs. Nanoformulated corn oil was evaluated on Ex vivo monocyte inflammatory, oxidative, pro-coagulant, and remodeling marker expression (IL-6, TNF-α, CD86, tissue factor, p47phox, ACE1, MMP-9, and ROS). Nanoformulated linseed oil reduced ex vivo monocyte inflammatory markers and ROS in 19 of 30 CAD patients via an FPR2-dependent mechanism, while 11 were non-responders.
Synapse has enriched 10 related papers. Consider them for comparative context: